Significant differences have been found in frequency of risk alleles in the HLA region and in PTPN22, CCR6, CD40, RASGRP1 and TAGAP genes between ACPA-positive and ACPA-negative RA patients [8, 9]. This evidence concerns the gene PTPN22 and rheumatoid arthritis.